Free Trial

PowerUp Acquisition (PWUP) Competitors

PowerUp Acquisition logo
$0.64 -0.02 (-3.03%)
As of 03/28/2025

PWUP vs. LSB, LPCN, MTEX, SNTI, CGTX, INAB, NXTC, MIRA, BCAB, and GLYC

Should you be buying PowerUp Acquisition stock or one of its competitors? The main competitors of PowerUp Acquisition include Lakeshore Biopharma (LSB), Lipocine (LPCN), Mannatech (MTEX), Senti Biosciences (SNTI), Cognition Therapeutics (CGTX), IN8bio (INAB), NextCure (NXTC), MIRA Pharmaceuticals (MIRA), BioAtla (BCAB), and GlycoMimetics (GLYC). These companies are all part of the "pharmaceutical products" industry.

PowerUp Acquisition vs.

PowerUp Acquisition (NASDAQ:PWUP) and Lakeshore Biopharma (NASDAQ:LSB) are both small-cap manufacturing companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, community ranking, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings.

PowerUp Acquisition has a beta of 0.05, indicating that its stock price is 95% less volatile than the S&P 500. Comparatively, Lakeshore Biopharma has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500.

19.2% of PowerUp Acquisition shares are owned by institutional investors. Comparatively, 52.6% of Lakeshore Biopharma shares are owned by institutional investors. 48.0% of PowerUp Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, PowerUp Acquisition and PowerUp Acquisition both had 1 articles in the media. Lakeshore Biopharma's average media sentiment score of 1.87 beat PowerUp Acquisition's score of 0.00 indicating that Lakeshore Biopharma is being referred to more favorably in the news media.

Company Overall Sentiment
PowerUp Acquisition Neutral
Lakeshore Biopharma Very Positive

PowerUp Acquisition has higher earnings, but lower revenue than Lakeshore Biopharma.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PowerUp AcquisitionN/AN/AN/AN/AN/A
Lakeshore Biopharma$672.27M0.03-$61.09MN/AN/A

Company Net Margins Return on Equity Return on Assets
PowerUp AcquisitionN/A N/A N/A
Lakeshore Biopharma N/A N/A N/A

PowerUp Acquisition and Lakeshore Biopharma both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
PowerUp AcquisitionN/AN/A
Lakeshore BiopharmaN/AN/A

Summary

Lakeshore Biopharma beats PowerUp Acquisition on 4 of the 5 factors compared between the two stocks.

Remove Ads
Get PowerUp Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for PWUP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PWUP vs. The Competition

MetricPowerUp AcquisitionHolding Offices IndustryManufacturing SectorNASDAQ Exchange
Market Cap$4.97M$444.26M$2.07B$7.84B
Dividend YieldN/A7.51%2.67%4.01%
P/E RatioN/A2.2023.5118.73
Price / SalesN/A58.6277.1490.75
Price / CashN/A69.01N/A34.64
Price / BookN/A3.511.944.23
Net IncomeN/A$35.22M-$463.10M$247.47M
7 Day Performance1.52%0.24%-1.75%-2.29%
1 Month Performance-63.22%-1.34%-3.41%-5.81%
1 Year Performance-94.19%16.53%3.04%-0.96%

PowerUp Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PWUP
PowerUp Acquisition
N/A$0.64
-3.0%
N/A-94.2%$4.97MN/A0.00N/ANews Coverage
High Trading Volume
LSB
Lakeshore Biopharma
1.499 of 5 stars
$2.05
+2.3%
N/AN/A$19.03M$672.27M0.00773Positive News
LPCN
Lipocine
2.075 of 5 stars
$3.50
+4.5%
$10.00
+185.7%
-36.9%$18.72M$7.92M-4.6110
MTEX
Mannatech
0.6999 of 5 stars
$9.92
-3.0%
N/A+7.4%$18.70M$121.55M-12.25250Earnings Report
Analyst Forecast
Gap Up
SNTI
Senti Biosciences
3.6902 of 5 stars
$3.87
+10.9%
$10.00
+158.4%
-9.0%$18.69M$2.56M-0.254Short Interest ↓
Positive News
Gap Up
CGTX
Cognition Therapeutics
3.7383 of 5 stars
$0.45
-0.1%
$8.30
+1,757.2%
-77.2%$18.57MN/A-0.4620Short Interest ↓
Analyst Revision
Gap Up
INAB
IN8bio
3.034 of 5 stars
$0.23
+0.4%
$6.75
+2,884.1%
-83.4%$18.38MN/A-0.3020Short Interest ↑
Gap Up
NXTC
NextCure
4.5359 of 5 stars
$0.64
-7.0%
$3.50
+446.4%
-77.6%$17.94MN/A-0.3190Gap Up
MIRA
MIRA Pharmaceuticals
1.9682 of 5 stars
$1.08
-8.5%
$14.00
+1,196.3%
-3.6%$17.89MN/A-1.932Earnings Report
Short Interest ↑
BCAB
BioAtla
2.1189 of 5 stars
$0.36
+4.9%
$6.00
+1,564.4%
-89.1%$17.43M$11M-0.2160Earnings Report
Short Interest ↑
News Coverage
Gap Down
GLYC
GlycoMimetics
1.8072 of 5 stars
$0.27
+2.1%
$8.00
+2,870.7%
-92.7%$17.37M$10,000.000.0050
Remove Ads

Related Companies and Tools


This page (NASDAQ:PWUP) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners